S52 Goosby et al J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, 2012
|
|
- Ellen Powers
- 6 years ago
- Views:
Transcription
1 SUPPLEMENT ARTICLE The United States President s Emergency Plan for AIDS Relief: A Story of Partnerships and Smart Investments to Turn the Tide of the Global AIDS Pandemic Eric Goosby, MD,* Mark Dybul, MD, Anthony A. Fauci, MD, Joe Fu, BS,* Thomas Walsh, JD, MPH,* Richard Needle, PhD, MPH,* and Paul Bouey, PhD, MPH* Abstract: The United States President s Emergency Plan for AIDS Relief (PEPFAR) has played a key leadership role in the global response to the HIV/AIDS pandemic. PEPFAR was inspired by the principles of the historic Monterrey Consensus (United Nations. Monterrey Consensus on Financing for Development, Monterrey, Mexico, March 18-22, New York: United Nations; Available at: Accessed April 21, 2012), which changed the underlying conceptual framework for international development, and therefore global health a shift from paternalism to partnership that begins with country ownership and requires good governance, a results-based approach, and engagement of all sectors of society. PEPFAR began with a focus on the growing emergency of the HIV/AIDS pandemic by rapidly expanding HIV services, building clinical capacity, implementing strategic information systems, and building a coalition of partners to lead the response. Within the first years of implementation, there was a shift to sustainability, including the advent of Partnership Frameworks. The PEP- FAR reauthorization in 2008 codified into law, the evolution in policies and programs for the next phase of implementation. In 2011 alone, PEPFAR supported nearly 4 million people on treatment, supported programs that provided more than 1.5 million HIVpositive pregnant women with antiretroviral drugs to prevent HIV transmission to their children, and supported HIV testing for more than 40 million people. This article provides an overview of how smart investments and partnerships across sectors and US agencies have helped achieve unprecedented results in increasing HIV/AIDS services and engaging partner countries and organizations in sharing the responsibility for an AIDS-free generation. Key Words: PEPFAR, HIV prevention, care, treatment (J Acquir Immune Defic Syndr 2012;60:S51 S56) From the *Office of the US Global AIDS Coordinator, Washington, DC; Georgetown University O Neill Institute for National and Global Health Law, Washington, DC; and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. Various authors have professional relationships with PEPFAR (either as employees of PEPFAR-supported US Government agencies or as grantees/ contractors) as outlined in the Copyright Transfer Agreement forms. The authors have no other funding or conflicts of interest to disclose. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the US Government, or the World Health Organization. Correspondence to: Joe Fu, BS, Office of the US Global AIDS Coordinator, 301 4th Street SW, #700, Washington, DC ( fujkh@state.gov). Copyright 2012 by Lippincott Williams & Wilkins INTRODUCTION On June 5, 1981, the Centers for Disease Control and Prevention s Morbidity and Mortality Weekly Report reported the first cases of the syndrome that would become known as AIDS. 1 For the next 2 decades, the United States led a vigorous multidisciplinary response ranging from academicbased research sponsored by the National Institutes of Health and other US government agencies, to drug development efforts by the private sector, to community-based activism. One of the most notable developments was the introduction of highly active antiretroviral therapy (ART) in the mid-1990s, which helped HIV-infected patients effectively manage the disease. Despite the advent of ART and many other advances, the HIV/AIDS pandemic in low- and middle-income countries continued to spread at a frightening pace. By 1999, UNAIDS estimated that 34 million people worldwide were living with HIV, with more than 20 million in sub-saharan Africa. In some countries such as Botswana, 1 of 3 adults was HIV-positive. 2 HIV/AIDS was growing as a scourge that destroyed families, marginalized persons, and disproportionately harmed children and women. 3 The HIV/AIDS pandemic became so severe that in 2000, it became the first health issue ever addressed by the United Nations Security Council. 4 The United States argued to the United Nations that emerging infectious diseases such as HIV/AIDS, if left unchecked, could affect national security by destabilizing political and economic systems and weakening the military. 5 8 At the time, data from the US Defense Intelligence Agency and the US Armed Forces Medical Intelligence Center suggested that HIV prevalence in the military in African countries ranged from 10% to 60%. 8 A consensus developed, shared by the Administrations of both Presidents Bill Clinton and George W. Bush, that US leadership was necessary to halt the spread of HIV/AIDS. 8 Although US agencies were already working on global AIDS programs, it became clear that a much larger initiative would be necessary to turn the tide of the pandemic. The First 5 Years In response to the growing emergency, President George W. Bush assembled a team to develop a transformative program to fight HIV/AIDS globally. 9 In his January 28, 2003 State of the Union Address, he announced a proposal to devote $15 billion over 5 years to a US-led international J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, S51
2 Goosby et al J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, 2012 AIDS program the President s Emergency Plan for AIDS Relief or PEPFAR the largest international health initiative in history to combat a single disease. Congress provided strong bipartisan support for PEPFAR and authorized it from 2004 to 2008 through the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of Figure 1 provides a timeline of major PEPFAR milestones. During the first 5 years, congressional appropriations for PEPFAR, more than $18 billion, exceeded the authorization. As of 2012, more than $37 billion has been provided for PEPFAR bilateral programs. PEPFAR represented a continuum of services to combat a chronic infectious disease. In fact, it represented the first time the US Government had directly supported interventions for a chronic disease a historic and lasting legacy of the program. By focusing on (1) preventing new infections, (2) providing compassionate care for those who did not yet need treatment and for orphans and vulnerable children, and (3) scaling up treatment, PEPFAR set a new standard for a comprehensive approach to combat HIV/AIDS. Although it is appropriate that much is made of the emergency response, the chronic nature of the disease required an early and intensive focus on capacity building to support national scale-up of prevention, care, and treatment services. PEPFAR intentionally and controversially supported national scale-up to promote country leadership and ownership by focusing resources on 15 nations in Africa, Asia, and the Caribbean that accounted for more than 50% of the world s infections. During the course of the first 5 years, the countries of particular focus continued to expand, eventually reaching more than 30. Also of great importance was accountability. Before PEPFAR, global health and development programs were often judged largely on the amount of resources committed rather than on results achieved. President Bush set, and a bipartisan Congress adopted, specific goals to support the prevention of 7 million new infections, treatment of 2 million HIV-positive persons, and compassionate care for up to 10 million people, including orphans and vulnerable children. An important and unique aspect of PEPFAR was the all of government approach from the beginning. Through the Office of the US Global AIDS Coordinator at the Department of State, PEPFAR developed a unique interagency model that implemented these policies with the combined strengths of multiple US agencies, including the Departments of State, Health and Human Services, and Defense, the US Agency for International Development, and the Peace Corps. Reauthorization In 2007, the Bush Administration put forward a proposal for reauthorizing PEPFAR. On July 30, 2008, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 was signed into law by President Bush, authorizing up to $48 billion over the next 5 years to combat the 3 diseases globally. President Barack Obama, then a Senator from Illinois, and Secretary Hillary Rodham FIGURE 1. Major milestones in PEPFAR ( ), Source: Author s notes; Office of the US Global AIDS Coordinator. S52
3 J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, 2012 Role of PEPFAR in Global AIDS Pandemic Clinton, then a Senator from New York, cosponsored the bill, which passed with bipartisan support. Vice President Biden, then the Chairman of the Senate Foreign Relations Committee, shepherded the bill through his chamber. Although PEP- FAR has always underscored the importance of country ownership and leadership of its response to its own HIV/ AIDS epidemic, the second phase of PEPFAR has accelerated the transition from an emergency response to one of sustainability that was begun in the first phase. Legislative language in the 2008 reauthorization codified the evolution of PEPFAR that had already begun with an emphasis on strengthening health care systems, including expansion of trained health workforce, and development of Partnership Frameworks (PFs) with host countries to promote country ownership and sustainability of programs. In terms of prevention, the reauthorization allowed greater flexibility to fund programs tailored to specific country needs. The Global Health Initiative and the Second PEPFAR Strategy On May 5, 2009, less than a year after PEPFAR s reauthorization, President Obama announced the launch of the Global Health Initiative (GHI), a 6-year interagency effort to support partner countries in improving and expanding access to health services. As the largest US bilateral health program, PEPFAR serves as a central part of the GHI. GHI provides a forum for interface between PEPFAR and other US programs in strengthening health systems, improving monitoring and evaluation, adopting a woman and girl centered approach to health and gender equity, and integrating across health and development programs. Six months later, PEPFAR released its second 5-year strategy 10, which provided a roadmap for sustainability by incorporating the goals of both reauthorization and GHI. The concept of country ownership, seeking to advance health programs that are locally owned and responsive to the needs of host country nationals, is reflected in the document. The strategy addresses HIV/AIDS within a broader health and development context by strengthening health systems, integrating and coordinating health interventions across health programs, such as tuberculosis (TB) and malaria, and linking HIV/AIDS to women s and children s health. It also heightened attention to concentrated and mixed epidemics outside of the original focus countries. In addition, the United States has maintained strong support for the Global Fund throughout the evolution of PEPFAR and GHI (discussed further below). US contributions to the Global Fund support the delivery of significant and concrete health results; expand the geographic reach of and enhance bilateral efforts; catalyze international investment in AIDS, TB, and malaria; build capacity, country ownership, and sustainability; and demonstrate political commitment to international cooperation. LATEST RESULTS Under the Obama Administration, PEPFAR has made unprecedented progress, building on the strong foundation laid under the Bush Administration. Figure 2 shows the number of persons directly supported on ART and PEPFAR funding from 2004 to UNAIDS estimated at the end of 2002 that only 50,000 persons were receiving treatment for HIV in sub-saharan Africa. In its first 8 years, PEPFAR has increased the number of persons it directly supports on treatment from 67,100 in 2004 to nearly 4 million in Between 2008 and 2011, in the midst of the global economic recession, PEPFAR significantly increased the number of people supported on ART. A recently presented evaluation showed that African countries supported by PEPFAR experienced a nearly FIGURE 2. PEPFAR funding and number of persons directly supported on ART ( ). Source: Office of the US Global AIDS Coordinator, WHO Universal Access Progress Reports. S53
4 Goosby et al J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, % decline in all-cause adult mortality during the first 5 years alone. 11 Investments made in volume-based pricing and generic drugs, new shipment modes, prevention interventions such as voluntary medical male circumcision (VMMC), and infrastructure and human resources built early in the PEPFAR program continue to support the gains made. Continued and evolving alignment of funding and programs with bilateral and multilateral partners has also stretched the impact of every dollar invested. In 2011, PEPFAR issued guidance on preventing the sexual transmission of HIV, focusing on a combination prevention approach tailored to specific circumstances in each country, building on combination prevention guidance previously issued. 12 Although there has, appropriately, been much focus on the expansion of treatment, it is important to note the significant progress on HIV prevention. According to UNAIDS, from 2000 to 2010, 33 countries 22 of them in sub-saharan Africa 13 experienced a greater than 25% decline in HIV prevalence. Moreover, demographic health surveys in Botswana, Namibia, and South Africa have shown up to 60% declines in new cases of HIV infection among one of the highest risk groups, young adults. 13 Recent scientific advances indicate that even greater gains can be made. In addition to saving lives of those on treatment, treatment of infected individuals presents an opportunity to save many more lives by preventing HIV transmission. In 2011, a study published by Cohen and colleagues demonstrated that ART, which dramatically lowers HIV viral load in infected persons, reduced the risk of heterosexual HIV transmission to an uninfected partner by 96% if started relatively early in the course of HIV disease (CD4 + T-cell count of cells/mm 3 ), rather than waiting for the immune system to deteriorate. 14 In essence, implementation of treatment of HIV-infected individuals can have the dual benefit of saving lives of infected individuals at the same time as preventing transmission of HIV to uninfected sexual partners. Reflecting its role of translating new science into policy to inform programs, PEPFAR is expanding its commitment to treatment, consistent with input from its Scientific Advisory Board on how to achieve the greatest possible benefits from this breakthrough. 15 The long-term savings and broader benefits that result from providing treatment also make it a valuable investment. Studies suggest that increasing ART coverage can avert costly and detrimental outcomes that extend beyond the patient receiving treatment by extending productive lifeyears, preventing transmission and stopping children from becoming orphaned. 16 On World AIDS Day 2011, President Obama announced PEPFAR s plan to support 6 million persons on treatment by 2013, 2 million more than the previous treatment goal. PEPFAR has also accelerated scale-up of prevention of mother-to-child transmission (PMTCT) efforts. Not only do PMTCT interventions reduce pediatric infections, they also provide a platform to treat infected mothers and prevent their other children from becoming orphans. In 2011, PEPFAR directly supported HIV testing and counseling (HTC) for more than 9.8 million pregnant women (+88% since 2008) and antiretroviral drug prophylaxis to prevent mother-to-child S54 transmission for more than 660,000 (+72% since 2008) of these women who tested positive for HIV. These efforts allowed approximately 200,000 infants to be born HIV-free. PEPFAR also directly supported nearly 13 million people (+55% since 2008) with care and support in 2011, including more than 4.1 million orphans and vulnerable children (+40% since 2008). In addition to PMTCT, a significant component of the PEPFAR combination prevention portfolio is dedicated to VMMC and programs for key populations at high risk. VMMC reduces the risk of heterosexual acquisition of HIV by men, and some studies suggest VMMC can decrease the incidence of infection of circumcised men by more than 70%. 17 VMMC is also highly cost effective, as a 1-time investment with an average cost/vmmc as low as $20 results in future net savings because of averted treatment and care costs. Since 2007, PEPFAR has supported over 800,000 VMMCs for HIV prevention. For key populations at high risk, there is substantial evidence that a core set of interventions can drastically reduce HIV prevalence and that reduction will also carry over into the general population. These groups include sex workers, men who have sex with men, and people who inject drugs. The latter 2 populations are the focus of PEPFAR prevention guidance documents, which are guiding expansion of interventions adapted for different subgroups especially vulnerable to HIV. This emphasis is especially important in countries with epidemics driven by these groups, where the interventions will have the greatest epidemiologic impact. In clinical trials, preexposure prophylaxis with antiretroviral drugs has been shown to reduce infections in men who have sex with men by 44%. 18 When adherence is high, reductions in transmissions have exceeded 90%. 18 Although other clinical trials have been less encouraging, perhaps because of poor adherence of volunteers to study drugs, preexposure prophylaxis with further development likely will prove to be useful as a targeted intervention to selected high-risk populations. HTC is an often-overlooked critical success factor for the expansion of prevention programming. Knowledge of one s HIV status is a prerequisite to accessing treatment and taking appropriate prevention steps to stay safe or protect others. PEPFAR directly supported HTC for more than 40 million people in fiscal year 2011, providing a critical entry point to prevention, treatment, and care. Further efforts to expand HTC, including the use of rapid test kits, will enable more widespread and routine testing both within and outside of health facilities. The integration of related health programs in TB and gender-based issues, which enhance PEPFAR s response to HIV/AIDS, has played a key role in PEPFAR s strategy since authorization. TB is the leading cause of death among people living with HIV. In 2011, PEPFAR-supported programs screened 3.8 million people living with HIV for TB in HIV care or treatment settings. In line with GHI principles, PEPFAR s gender strategy recognizes that addressing gender norms and inequities is essential to reducing HIV risk and increasing access to HIV prevention, care, and treatment services for both women
5 J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, 2012 Role of PEPFAR in Global AIDS Pandemic and men. In low- and middle-income countries worldwide, HIV is the leading cause of death and disease in women in reproductive age; and in sub-saharan Africa, 60% of those living with HIV are women. Over the last 2 years, PEPFAR has invested a total of $155 million in gender-based violencerelated programming, making PEPFAR one of the largest investors worldwide. PEPFAR has also invested in special gender initiatives to pilot specific approaches, build our evidence base for investments, and expand programming at the country level. The drivers behind these exceptional results and the associated challenges and opportunities are thoroughly and thoughtfully examined in the articles throughout this supplement. A STORY OF PARTNERSHIPS PEPFAR s ability to scale-up HIV services has benefited from leveraging the core competencies of partners across multiple sectors and uniting them in the shared goal of saving lives. The idea of country ownership is a constant theme throughout PEPFAR, particularly in its second phase, as more attention is being paid to how we can better integrate country ownership into all aspects of program. Although always a complex process, the value of country ownership is essential to the long-term viability of a robust health system that is locally owned and led by a country s stakeholders in a sustained response to the epidemic. Bilaterally, Partnership Frameworks (PFs) have embodied this concept. These provide 5-year joint strategic frameworks for cooperation between the United States, the partner government, and other partners to combat HIV/AIDS in country through service delivery, policy reform, and coordinated financial commitments. As of 2011, 21 PFs have been signed with countries and regions around the world. In many cases, PFs build on and complement the work accomplished in the beginning years of PEPFAR, when the United States, United Kingdom, and UNAIDS supported the development of the 3 Ones strategy including a commitment to support one national AIDS strategy that brings together and aligns the efforts and contributions of many partners. 19 Global AIDS is a shared responsibility at the country level, a mix of resources from bilateral programs such as PEPFAR, host countries, and multilateral partners is required. The Global Fund represents the largest multilateral funding mechanism for responses to the 3 diseases. The United States is the largest contributor to the Global Fund, accounting for nearly one-third of total commitments. In addition, PEPFAR and the Global Fund are highly interdependent in support of country HIV programming. Figure 3 shows not only the combined global scale-up of treatment by PEPFAR and Global Fund (5.6 million persons in 2011) but also their coordinated support of more than 70% of all persons on ART worldwide in Within many countries, this combined support is so integrated that many individual patients depend on both PEPFAR and the Global Fund for support. More recently, US leadership has led to increased collaboration to improve grant management and implementation as part of an overall strategy to link US commitments to reforms, which will help ensure that every dollar invested is maximized to save lives helping in turn to convince donors that investments in the fund are sound ones. Faith-based organizations and civil society are critical elements of health systems in the developing world. An engaged and supported civil society is an essential part of the move toward country ownership of effective national HIV/AIDS responses, often serving as the only option for people who live in rural areas and for populations that are most at risk. Private public partnerships, which add the skills and core competencies of the private sector, have also played an essential role in strengthening PEPFAR s response. FIGURE 3. Persons directly supported by PEPFAR and the Global Fund on ART ( ). Source: The Global Fund, Office of the US Global AIDS Coordinator, World Health Organization. At the time of publication, data on the percentage of all persons on treatment in lowand middle-income countries supported by PEPFAR and the Global Fund in 2011 was unavailable. S55
6 Goosby et al J Acquir Immune Defic Syndr Volume 60, Supplement 3, August 15, 2012 Equally important is the thoughtful engagement of policy makers, implementers, advocates, and agency officials who work across disciplines and share expertise in making PEPFAR a stronger program. Ultimately, partnerships across sectors and US agencies have helped PEPFAR achieve unprecedented results in increasing HIV services and engaging partner countries and organizations in sharing the responsibility of easing the burden of HIV/AIDS. CONCLUSIONS With a large and continuing need for HIV services, in an era of constrained resources, PEPFAR will surely confront new challenges. PEPFAR s history of bringing together multiple sectors, countries, and administrations, and its commitment to scale-up of evidence-based, cost-efficient, and effective interventions offer encouragement for the road ahead. PEPFAR will continue to translate promising scientific discoveries and operations and implementation research into lifesaving public health programs and policies. This is an important juncture for the global AIDS response. Just as the second phase of PEPFAR built on and improved on the lessons learned in the first 5 years, the next phase of PEPFAR will grow from the strong foundation laid over the past decade. In the end, PEPFAR s success past and future is the success of the innovative, talented, and creative people in the countries that it supports and serves. It is a success of the American people acting on their deeply rooted belief in the dignity and worth of every person. It is, fundamentally, a story of the human spirit. REFERENCES 1. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Vol 50. Atlanta, GA: CDC; Available at: Accessed April 20, UNAIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland: UNAIDS; Altman LK. More African women have AIDS than men. New York Times. November 24, Available at: world/more-african-women-have-aids-than-men.html. Accessed June 20, The White House, Office of the Vice President. Remarks Prepared for Delivery by Vice President Al Gore, United Nations Security Council Opening Session. Washington, DC: White House; Gordon DF. The Global Infectious Disease Threat and Its Implications for the United States. Washington, DC: National Intelligence Council (NIC), NIE 99 17D, Available at: globalinfectious.html. Accessed March 29, Singer PW. AIDS and international security. Survival. 2002;44: Sachs J. The best possible investment in Africa. New York Times. February 10, 2001:A Feldbaum H, Lee K, Patel P. The national security implications of HIV/AIDS. PLoS Med. 2006;3:e Fauci AS. A view from Washington through the eyes of an AAP physicianscientist. J Clin Invest. 2007;117: PEPFAR. Five-Year Strategy. Washington, DC: OGAC; Available at: Accessed April 20, Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA. 2012;307(19): PEPFAR. PEPFAR Prevention Guidance. Washington, DC: OGAC; Available at: Accessed April 20, World Health Organization, UNAIDS, UNICEF. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011 [Internet]. Geneva: WHO, UNAIDS, UNI- CEF; Available at: _eng.pdf. Accessed June 20, Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365: Available at: Accessed April 11, PEPFAR. PEPFAR Scientific Advisory Board Recommendations for the Office of the US Global AIDS Coordinator: Implications of HPTN 052 for PEPFAR s Treatment Programs. Washington, DC: OGAC; Available at: pdf. Accessed April 20, Blandford J. The Impact of Treatment as Prevention Models to Guide Ending the Epidemic. New York: AVAC Webinar; Available at: Accessed April 20, Gray R, Kigozi G, Kong X, Ssempiija V, Makumbi F, Wattya S, Serwadda D, Nalugoda F, Sewenkambo NK, Wawer MJ. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS. 2012;26(5): Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363: UNAIDS. The Three Ones in Action: Where We Are and Where We Go From Here. Geneva, Switzerland: UNAIDS; Available at: Accessed April 20, S56
The U.S. President s Emergency Plan for AIDS Relief (PEPFAR)
The U.S. President s Emergency Plan for AIDS Relief (PEPFAR) Although the U.S. has been involved in efforts to address the global AIDS crisis since the mid-1980s, the creation of the President s Emergency
More informationFinancial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment
Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Joint WHO & UNAIDS Consultation with Pharmaceuticals and Stakeholders November 05 2012 Lara Stabinski, MD, MPH Medical
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationMonitoring of the achievement of the health-related Millennium Development Goals
SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered
More informationPeace Corps Global HIV/AIDS Strategy (FY )
The Peace corps :: global hiv/aids str ategy :: fisc al years 2009 2014 1 of 5 Peace Corps Global HIV/AIDS Strategy (FY 2009 2014) 2007 facts BacKGroUnd 33 million people are living with hiv. More than
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationU.S. Response to the Global Threat of HIV/AIDS: Basic Facts
U.S. Response to the Global Threat of HIV/AIDS: Basic Facts Alexandra E. Kendall Analyst in Global Health February 22, 2011 Congressional Research Service CRS Report for Congress Prepared for Members and
More informationPromoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia
Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia The Global Health Initiative (GHI) is an integrated approach to global health
More informationAUGUST 200 JULY Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act:
Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act: JULY 2008 AUGUST 200 A Side-by-Side Comparison to Current Law Reauthorization of PEPFAR, The United
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationThe road towards universal access
The road towards universal access JAN 2006 Issues Paper Requests... that the UNAIDS Secretariat and its Cosponsors assist in facilitating inclusive, country-driven processes, including consultations with
More informationChildren and AIDS Fourth Stocktaking Report 2009
Children and AIDS Fourth Stocktaking Report 2009 The The Fourth Fourth Stocktaking Stocktaking Report, Report, produced produced by by UNICEF, UNICEF, in in partnership partnership with with UNAIDS, UNAIDS,
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More informationFAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030
Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationThe President s Emergency Plan For AIDS Relief: Marshalling All Tools At Our Disposal Toward An AIDS-Free Generation
By Eric Goosby ANALYSIS & COMMENTARY The President s Emergency Plan For AIDS Relief: Marshalling All Tools At Our Disposal Toward An AIDS-Free Generation doi: 10.1377/hlthaff.2012.0241 HEALTH AFFAIRS 31,
More informationAddressing the Global HIV Epidemic Among Pregnant Women, Mothers, Children and Adolescents
TOWARDS 2030: UNICEF S GLOBAL HIV RESPONSE FOR 2018-2021 Addressing the Global HIV Epidemic Among Pregnant Women, Mothers, Children and Adolescents UNICEF s Global HIV Response 2018 2021 TOWARDS 2030:
More informationAntiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND
KEY MESSAGES New WHO Recommendations: Antiretroviral therapy for adults and adolescents The World Health Organization (WHO) is revising its guidelines on antiretroviral therapy (ART) for adults and adolescents.
More information1. The World Bank-GAVI Partnership and the Purpose of the Review
1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective
More informationThe road towards universal access
The road towards universal access Scaling up access to HIV prevention, treatment, care and support 22 FEB 2006 The United Nations working together on the road towards universal access. In a letter dated
More informationACHAP LESSONS LEARNED IN BOTSWANA KEY INITIATIVES
ACHAP Together with our company s foundation, a U.S.-based, private foundation, and the Bill & Melinda Gates Foundation, we established the African Comprehensive HIV/AIDS Partnerships (ACHAP) in 2000 to
More informationEmergency Plan. Pink Ribbon Red. under President. With. screened and Significantly. Commitments: to catalyze. a dynamic, including. of shared.
Pink Ribbon Red Ribbon Overview Pink Ribbon Red Ribbon is an innovative partnership to leverage public and private investments in global health to combat cervical and breast cancer two of the leading causes
More informationPresentation to the Institute of Medicine Outcome and Impact Evaluation Committee February 22, 2011
PEPFAR Moving Forward: Shared Responsibility, Smart Investments, Promoting Security, Saving Lives Presentation to the Institute of Medicine Outcome and Impact Evaluation Committee February 22, 2011 PEPFAR:
More informationRe: Civil Society Submission for Six-Month Review of Protecting Life in Global Health Assistance Implementation
October 15, 2017 The Honorable Secretary of State Rex W. Tillerson U.S. Department of State 2201 C Street, N.W. Washington, D.C. 20520 Re: Civil Society Submission for Six-Month Review of Protecting Life
More informationART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
More informationPopulation Council Strategic Priorities Framework
Population Council Strategic Priorities Framework For 65 years, the Population Council has conducted research and delivered solutions that address critical health and development issues and improve lives
More informationBotswana Private Sector Health Assessment Scope of Work
Example of a Scope of Work (Botswana) Botswana Private Sector Health Assessment Scope of Work I. BACKGROUND The Republic of Botswana is a stable, democratic country in Southern Africa with an estimated
More information2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030
S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationThe Strategy Development Process. Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015
The Strategy Development Process Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015 Structure of the current 2012-16 Global Fund Strategy The 2012-16 Global Fund Strategy.. States a forward
More informationThe President s Emergency Plan for AIDS Relief Next Generation Indicators
The President s Emergency Plan for AIDS Relief Next Generation Indicators PEPFAR Next Generation Working in partnership with host nations, PEPFAR will support the following legislative goals: Treatment
More informationInstitute of Medicine. The President s Emergency Plan Strategic Information April 21, 2005
Institute of Medicine The President s Emergency Plan Strategic Information April 21, 2005 Questions of Interest What is the framework to evaluate The Emergency Plan? Measuring impact and outcomes Evidence-based
More informationProgress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa
SUMMARY REPORT Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa January December 2012 Table of contents List of acronyms 2 Introduction 3 Summary
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationCelebrating Life: The U.S. President s Emergency Plan for AIDS Relief Annual Report to Congress - Highlights
Celebrating Life: The U.S. President s Emergency Plan for AIDS Relief 2009 Annual Report to Congress - Highlights AIDS. Until recently, many wondered whether prevention, treatment and care could ever make
More informationCopenhagen, Denmark, September August Malaria
Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support
More informationThe United States President s Emergency Plan for AIDS Relief Food & Nutrition Support within PEPFAR Programs
The United States President s Emergency Plan for AIDS Relief Food & Nutrition Support within PEPFAR Programs Partners in Health Conference Cambridge, MA October 12, 2007 Michele Moloney-Kitts, C.N.M. Director,
More informationGeneral Assembly. United Nations A/63/152/Add.1
United Nations General Assembly Distr.: General 8 May 2009 Original: English Sixty-third session Agenda items 41 and 124 Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration
More informationUNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP
UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP WHY UNAIDS NEEDS YOUR SUPPORT Over the past 35 years, HIV has changed the course of history. The massive global impact of AIDS in terms
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationTechnical Guidance for Global Fund HIV Proposals
Technical Guidance for Global Fund HIV Proposals Broad Area Intervention Area CARE ANS SUPPORT Protection, care and support of children orphaned and made vulnerable by HIV and AIDS Working Document Updated
More informationConcept note. 1. Background and rationale
Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL
More informationSPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.
SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and
More informationNAMIBIA INVESTMENT CASE
NAMIBIA INVESTMENT CASE OUTLINE Why an Investment Case for HIV Response in Namibia? Investment Scenarios Can we achieve Fast Track and End AIDS as public health threat by 2030? Can we afford it? Efficiencies:
More informationENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS
ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS Strategic plan for the Africa CDC March 24-25, 2017 The Ebola outbreak underscored the fact that 2 pandemics are not just a
More informationProject Name Barbados-HIV/AIDS Prevention and Control Project ID
Report No. PID10562 Project Name Barbados-HIV/AIDS Prevention and Control (@)... Project Region Sector Project ID Latin America and the Caribbean (LCR) Other Population; Health & Nutrition BBPE75220 Borrower
More informationThe Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1
Resolution 2010/24 The role of the United Nations system in implementing the ministerial declaration on the internationally agreed goals and commitments in regard to global public health adopted at the
More informationWhich Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018
Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018 Outline Scaling up for Impact Critical Point of the Response Choices of strategies Accelerating Implementation
More informationSuraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
More informationTHE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH ( )
THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH (2016-2030) SURVIVE THRIVE TRANSFORM AT A GLANCE SURVIVE THRIVE TRANSFORM The Global Strategy for Women s, Children s and Adolescents
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
More informationThe HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)
Written Testimony for the Record to the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY 2018 Appropriations for HIV/AIDS Programs Submitted by Dr. Wendy
More informationWHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections
Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections
More informationLatest Funding Trends in AIDS Response
Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July
More informationENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
More informationUniting the world against AIDS
Uniting the world against AIDS A letter from Peter Piot, Executive Director For over 27 years, our world has been living with HIV. And in just this short time, AIDS has become one of the make-or-break
More informationCatalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030
Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework
More information1.2 Building on the global momentum
1.1 Context HIV/AIDS is an unprecedented global development challenge, and one that has already caused too much hardship, illness and death. To date, the epidemic has claimed the lives of 20 million people,
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationSPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV
SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV PREVENTION COALITION MEETING, 10 OCTOBER2017 I have said many times, and wish to repeat, that
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationThe outlook for hundreds of thousands adolescents is bleak.
Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds
More informationBotswana Advocacy paper on Resource Mobilisation for HIV and AIDS
Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.
More informationEconomic and Social Council
United Nations Economic and Social Council Distr.: General 18 November 2014 Original: English Economic and Social Commission for Asia and the Pacific Asia-Pacific Intergovernmental Meeting on HIV and AIDS
More informationChallenges and Opportunities for Responding to HIV/AIDS in LDCs. Mazuwa Banda Department of HIV/AIDS World Health Organization
Challenges and Opportunities for Responding to HIV/AIDS in LDCs Mazuwa Banda Department of HIV/AIDS World Health Organization Outline of Presentation Global HIV/AIDS epidemic HIV/AIDS and LDCs Challenges
More informationSexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012
Sexual and Reproductive Health and HIV Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Global estimates of HIV-(2009) People living with HIV 33.3 million [31.4 35.3
More informationSix things you need to know
UNAIDS Report 2010 MDG 6 Six things you need to know about the AIDS response today UNAIDS Report 2010 MDG 6 Six things you need to know about the AIDS response today MDG6: Combat HIV/AIDS, Malaria and
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More information39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016
8 December 2016 39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 6-8 December 2016 Decisions The UNAIDS Programme Coordinating Board, Recalling that all aspects of UNAIDS work
More informationSCALING UP TOWARDS UNIVERSAL ACCESS
SCALING UP TOWARDS UNIVERSAL ACCESS Considerations for countries to set their own national targets for HIV prevention, treatment, and care April 2006 Acknowledgements: The UNAIDS Secretariat would like
More informationPublic health dimension of the world drug problem
SEVENTIETH WORLD HEALTH ASSEMBLY A70/29 Provisional agenda item 15.3 27 March 2017 Public health dimension of the world drug problem Report by the Secretariat 1. The Executive Board at its 140th session
More informationADVANCE UNEDITED E/CN.6/2008/L.5/REV.1. Women, the girl child and HIV/AIDS * *
E/CN.6/2008/L.5/REV.1 ADVANCE UNEDITED Women, the girl child and HIV/AIDS The Commission on the Status of Women, Reaffirming the Beijing Declaration 1 and Platform for Action, 2 the outcome documents of
More informationENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
More informationTable of Contents. NASTAD s Technical Assistance to the HIV & AIDS District Coordination
Table of Contents Acronyms... 2 Acknowledgement... 3 Background... 4 Facilitators of the District HIV and AIDS Response... 6 District Multi-Sectoral AIDS Committee... 6 District AIDS Coordinators and Assistant
More informationLinkages between Sexual and Reproductive Health and HIV
Linkages between Sexual and Reproductive Health and HIV Manjula Lusti-Narasimhan Department of Reproductive Health and Research World Health Organization The HIV pandemic 25 years 1981 2006 Rationale for
More informationPROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name
PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name HIV/AIDS Project Region AFRICA Sector Health (60%); Other social services (23%); General public administration sector (10%);Central
More information1. POSITION TITLE : Technical Advisor, TB and HIV. 2. PERIOD OF PERFORMANCE : Two (2) years, with the possibility of
VACANCY POSITION GLOBAL FUND COORDINATING UNIT (GFCU) 1. POSITION TITLE : Technical Advisor, TB and HIV 2. PERIOD OF PERFORMANCE : Two (2) years, with the possibility of 3. PLACE OF PERFORMANCE : Maseru,
More informationPartnerships between UNAIDS and the Faith-Based Community
Partnerships between UNAIDS and the Faith-Based Community Sally Smith- Partnership Adviser. Micah Network: Global Consultation-Churches Living with HIV Pattaya Thailand October 2008 UNAIDS Summary of 2008
More informationU.S. Response to the Global Threat of Malaria: Basic Facts
U.S. Response to the Global Threat of Malaria: Basic Facts Alexandra E. Kendall Analyst in Global Health June 15, 2012 CRS Report for Congress Prepared for Members and Committees of Congress Congressional
More informationBD-PEPFAR Labs for Life Partnership
BD-PEPFAR Labs for Life Partnership Renuka Gadde BD Global Health Jane Mwangi Division of Global HIV & TB, CDC Kenya FORUM ON PUBLIC-PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY October 27-28, 2016
More informationASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030
ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030 1. WE, the Heads of State and Government of the Association of Southeast
More informationADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA
ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA Wherever inequality lives, there stands a girl or woman able to turn the tide of adversity into a tidal wave
More informationINTERNAL QUESTIONS AND ANSWERS DRAFT
WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving
More informationHIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director
HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director June 16, 2014 On May 28, the National Institutes of Health (NIH) HIV/AIDS Research Portfolio Review Working
More informationGlobal Strategy for Women s, Children s and Adolescents Health
Global Strategy for Women s, Children s and Adolescents Health ANNOTATED OUTLINE HIGHLIGHTS Dr. Flavia Bustreo, World Health Organization on behalf of the Global Strategy 2015 Writing Team London, April,
More informationAge of Consent for HIV Testing, Counseling and Treatment in Tanzania
I. Introduction This assesses the legal environment in Tanzania regarding the age of consent for HIV/AIDS testing and counseling ( HTC ), compares the current legal framework for age of consent for HTC
More informationLAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005
LAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005 Excellencies, distinguished guests, ladies and gentlemen. On behalf of UNICEF, let
More informationREGIONAL COMMITTEE FOR AFRICA AFR/RC54/14 Rev June 2004
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR AFRICA ORGANISATION MONDIALE DE LA SANTE BUREAU REGIONAL DE L AFRIQUE ORGANIZAÇÃO MUNDIAL DE SAÚDE ESCRITÓRIO REGIONAL AFRICANO REGIONAL COMMITTEE FOR AFRICA
More informationToyako Framework for Action on Global Health - Report of the G8 Health Experts Group -
Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group - 8 July 2008 This report is the recommendation from the G8 Health Experts Group to the G8 leaders. I Introduction 1.
More information22 USC NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see
TITLE 22 - FOREIGN RELATIONS AND INTERCOURSE CHAPTER 83 - UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA SUBCHAPTER I - POLICY PLANNING AND COORDINATION 7611. Development of a comprehensive,
More informationWhy should AIDS be part of the Africa Development Agenda?
Why should AIDS be part of the Africa Development Agenda? BACKGROUND The HIV burden in Africa remains unacceptably high: While there is 19% reduction in new infections in Sub-Saharan Africa, new infections
More informationPRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN
PRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN 2010-2012 INTRODUCTION PEP entered 2009 with the energy and optimism that the 2008 elections had reawakened in communities and individuals across
More informationHIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017
HIV in Women Why We Need Female- controlled Prevention Heather Watts, MD March 21, 2017 Since the Start of PEPFAR, New HIV Infections Have Declined 51-76% 1.6 Reduction in rate of new HIV infections (incidence
More informationREPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES
Information Brief: REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES Family Care International (FCI) developed this information brief as part of the Mobilising Advocates
More informationADOLESCENTS AND HIV:
Elizabeth Glaser Pediatric AIDS Foundation Until no child has AIDS. Photo by Eric Bond/EGPAF, 2015 ADOLESCENTS AND HIV: PRIORITIZATION FOR ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION PROGRAMS, ADVOCACY
More informationRAPID DIAGNOSIS AND TREATMENT OF MDR-TB
RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationRoche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics
Media Release June 18, 2015 Roche to provide HIV diagnostic solutions to Global Fund Framework agreement with Global Fund strengthens access to HIV diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced
More informationTranslating Science to end HIV in Latin America and the Caribbean
Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP
More information